BML Capital Management, LLC Q4 2024 Filing
Filed February 7, 2025
Portfolio Value
$161.0B
Holdings
25
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (25 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ACRSACLARIS THERAPEUTICS INC | 14,250,000 | $35.3B | 21.95% | |
| 2 | SGOVISHARES TR | 260,000 | $26.1B | 16.20% | |
| 3 | AVIRATEA PHARMACEUTICALS INC | 7,608,312 | $25.5B | 15.83% | |
| 4 | AVU0ADVERUM BIOTECHNOLOGIES INC | 2,268,064 | $10.6B | 6.58% | |
| 5 | ANTXAN2 THERAPEUTICS INC | 5,749,432 | $7.9B | 4.93% | |
| 6 | TILINSTIL BIO INC | 400,000 | $7.6B | 4.74% | |
| 7 | EPIEURESSA PHARMA INC | 4,221,546 | $7.6B | 4.69% | |
| 8 | WHWKAADI BIOSCIENCE INC | 2,100,000 | $6.6B | 4.12% | |
| 9 | ORMPORAMED PHARMACEUTICALS INC | 2,643,907 | $6.4B | 3.97% | |
| 10 | —IKENA ONCOLOGY INC | 3,585,866 | $5.9B | 3.65% | |
| 11 | PMVPPMV PHARMACEUTICALS INC | 3,466,684 | $5.2B | 3.25% | |
| 12 | 698ACHILLES THERAPEUTICS PLC | 4,100,002 | $4.7B | 2.90% | |
| 13 | CNTBCONNECT BIOPHARMA HLDGS LTD | 2,093,232 | $2.9B | 1.79% | |
| 14 | MISTMILESTONE PHARMACEUTICALS IN | 1,136,091 | $2.7B | 1.67% | |
| 15 | —ATHIRA PHARMA INC | 2,775,885 | $1.6B | 1.01% | |
| 16 | ASTCASTROTECH CORP | 220,410 | $1.5B | 0.92% | |
| 17 | LSTALISATA THERAPEUTICS INC | 284,669 | $848.3M | 0.53% | |
| 18 | PVLAPALVELLA THERAPEUTICS INC NE | 42,130 | $505.6M | 0.31% | |
| 19 | VTGNVISTAGEN THERAPEUTICS INC | 150,000 | $442.5M | 0.27% | |
| 20 | KZRKEZAR LIFE SCIENCES INC | 48,668 | $327.0M | 0.20% | |
| 21 | LENZLENZ THERAPEUTICS INC | 9,271 | $267.7M | 0.17% | |
| 22 | NXTCNEXTCURE INC | 273,536 | $210.9M | 0.13% | |
| 23 | VRCAVERRICA PHARMACEUTICALS INC | 174,651 | $122.3M | 0.08% | |
| 24 | —ALLOVIR INC | 184,246 | $77.4M | 0.05% | |
| 25 | HLVXHILLEVAX INC | 20,760 | $43.0M | 0.03% |